kidney
AZ licenses kidney drug from Ionis for $330m
February 21, 2018Research and Development, Sales and Marketing AstraZeneca, Ionis, Isis, biotech, drugs, kidney, pharma, pharmaceutical
AstraZeneca continues to build on its relationship with San Diego-based Ionis Pharmaceuticals, this time by agreeing a licensing deal for …
Keryx Biopharmaceuticals announces positive Phase III study results for anaemia treatment
March 30, 2016Research and Development CKD, anaemia, chronic kidney disease, clinical trial, dialysis, keryx, keryx biopharmaceuticals, kidney, phase 3, phase III
Keryx Biopharmaceuticals (NASDAQ: KERX) has announced positive top-line results for its Phase III study of ferric citrate for the treatment …
Novel device could help fight kidney disease
February 24, 2015Research and Development, Sales and Marketing Bio Nano Consulting, Pfizer, QELFA, Rapamune, device, ime, kidney
A novel device that combines nanotechnology and a pregnancy tester could help treat kidney disease, according to a report by …
Research pact joins Pfizer and Merck Serono with academics
April 3, 2014Research and Development, Sales and Marketing Lupus, Merck Serono, Pfizer, broad institute, emd, kidney
Merck’s US affiliate EMD Serono and Pfizer have entered into a research agreement with the Broad Institute to investigate autoimmune …
Novartis signs Regenerex deal
September 9, 2013Sales and Marketing CLL, Novartis, kidney, regenerex
Novartis has signed a deal with US biopharma firm Regenerex to use its novel stem cell-based platform, which may have …
AstraZeneca signs $350m kidney deal
August 1, 2013Sales and Marketing AstraZeneca, CKD, fibrogen, kidney
AstraZeneca has signed a deal with private biotech company FibroGen to develop a novel compound aimed at treating anaemia associated …
Abbott pulls kidney disease trial
October 22, 2012Research and Development, Sales and Marketing Abbott, Reata, kidney
Abbott has terminated its Phase III trial of bardoxolone methyl in patients with kidney disease and diabetes after concerns over …
